Paper29862152
The expression and clinicopathological role of CDX2 in intrahepatic cholangiocarcinoma.
Tang H and 3 others. Intractable Rare Dis Res, 2018. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. The expression and clinicopathological role of CDX2 in intrahepatic cholangiocarcinoma. Papers, record 29862152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29862152
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15645288 | Expression of homeodomain protein CDX2 in gallbladder carcinomas. | J Cancer Res Clin Oncol | 2005 | https://conductscience.org/library/papers/15645288 | PubMed |
| 2 | 28415734 | Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysis. | Oncotarget | 2017 | https://conductscience.org/library/papers/28415734 | PubMed |
| 3 | 17032404 | Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States. | Liver Int | 2006 | https://conductscience.org/library/papers/17032404 | PubMed |
| 4 | 26789870 | CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. | N Engl J Med | 2016 | https://conductscience.org/library/papers/26789870 | PubMed |
| 5 | 16866857 | Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus. | Dis Esophagus | 2006 | https://conductscience.org/library/papers/16866857 | PubMed |
| 6 | 16144916 | Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis. | Clin Cancer Res | 2005 | https://conductscience.org/library/papers/16144916 | PubMed |
| 7 | 12368220 | Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis. | Am J Pathol | 2002 | https://conductscience.org/library/papers/12368220 | PubMed |
| 8 | 21577322 | Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma. | Int J Clin Exp Pathol | 2011 | https://conductscience.org/library/papers/21577322 | PubMed |
| 9 | 18329969 | Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges? | Dig Liver Dis | 2008 | https://conductscience.org/library/papers/18329969 | PubMed |
| 10 | 11304800 | A new rapid immunohistochemical staining technique using the EnVision antibody complex. | J Histochem Cytochem | 2001 | https://conductscience.org/library/papers/11304800 | PubMed |
| 11 | 21221877 | Expression of CDX2 and hepatocyte antigen in benign and malignant lesions of gallbladder and its correlation with histopathologic type and clinical outcome. | Pathol Oncol Res | 2011 | https://conductscience.org/library/papers/21221877 | PubMed |
| 12 | 12560917 | Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa. | J Gastroenterol | 2003 | https://conductscience.org/library/papers/12560917 | PubMed |
| 13 | 25343089 | Classification and management of hepatolithiasis: A high-volume, single-center's experience. | Intractable Rare Dis Res | 2012 | https://conductscience.org/library/papers/25343089 | PubMed |
| 14 | 11875002 | Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. | Gastroenterology | 2002 | https://conductscience.org/library/papers/11875002 | PubMed |
| 15 | 11040183 | Cdx1 and cdx2 expression during intestinal development. | Gastroenterology | 2000 | https://conductscience.org/library/papers/11040183 | PubMed |
| 16 | 9593754 | Expression of the Cdx1 and Cdx2 homeotic genes leads to reduced malignancy in colon cancer-derived cells. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9593754 | PubMed |
| 17 | 27583880 | Influence of surgical margins on overall survival after resection of intrahepatic cholangiocarcinoma: A meta-analysis. | Medicine (Baltimore) | 2016 | https://conductscience.org/library/papers/27583880 | PubMed |
| 18 | 22146627 | Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study. | Hepatobiliary Pancreat Dis Int | 2011 | https://conductscience.org/library/papers/22146627 | PubMed |
| 19 | 27026485 | The current management of cholangiocarcinoma: A comparison of current guidelines. | Biosci Trends | 2016 | https://conductscience.org/library/papers/27026485 | PubMed |
| 20 | 21425151 | Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. | Cancer | 2011 | https://conductscience.org/library/papers/21425151 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40751531 | Clinicopathological Perspectives of Liver Mass Biopsies: A Single Center Experience of 406 Cases. | Arch Iran Med | 2025 | https://conductscience.org/library/papers/40751531 | PubMed |
| 36457589 | Comparison of current guidelines and consensus on the management of patients with cholangiocarcinoma: 2022 update. | Intractable Rare Dis Res | 2022 | https://conductscience.org/library/papers/36457589 | PubMed |
| 34780466 | Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma. | PLoS One | 2021 | https://conductscience.org/library/papers/34780466 | PubMed |
| 32715002 | 68Ga-Prostate-Specific Membrane Antigen, A Potential Radiopharmaceutical in PET/CT To detect primary Cholangiocarcinoma. | Asia Ocean J Nucl Med Biol | 2020 | https://conductscience.org/library/papers/32715002 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CDX2 | 1045 | PubTator's text mining | https://conductscience.org/library/genes/1045 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29862152
GET https://conductscience.org/api/papers/v1/29862152/references?page=2